Respiratory syncytial virus infection in children with neuromuscular impairment

Arne Simon1, Julia Prusseit, Andreas Müller

  • 1University of Saarland, Paediatric Oncology and Haematology, Infectious Diseases Kirrberger Str., Building 9, 66421 Homburg/Saar, Germany.

Insights

Children with neurological impairment (NMI) face severe risks from viral respiratory infections due to various health factors. Prompt viral testing and preventative measures like palivizumab are crucial for managing these vulnerable children.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Children with neurological impairment (NMI) are at higher risk for severe outcomes from viral respiratory tract infections.
  • Factors contributing to this severity include impaired respiratory mechanics, compromised airway clearance, and altered immune responses.

Purpose of the Study:

  • To outline the clinical vulnerabilities of children with NMI to viral respiratory infections.
  • To recommend diagnostic and preventative strategies for managing these infections in this population.

Main Methods:

  • Literature review of clinical factors predisposing children with NMI to severe respiratory infections.
  • Analysis of diagnostic and prophylactic recommendations for viral respiratory infections in NMI patients.

Main Results:

  • Children with NMI exhibit multiple risk factors for severe viral respiratory infections, including reduced vital capacity, poor secretion clearance, and malnutrition.
  • Early clinical deterioration, metabolic disturbances, and seizures can occur.
  • Nasopharyngeal viral detection and strict infection control are recommended for hospitalized children.

Conclusions:

  • Children with NMI require vigilant management during viral respiratory seasons.
  • Prompt viral diagnostics, adherence to infection control protocols, and consideration of palivizumab for eligible infants are essential for improving outcomes.

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...